GE: Contrast media supplies returning to normal after shortage
GE Healthcare expects supplies of its iohexol and iodixanol intraveneous contrast media products for computed tomography imaging to return to normal in the next few weeks. Customers can check this webpage weekly for an update on stock availability. A COVID-19 lockdown in China last year temporarily shut down the company’s production facility for iodinated contrast media, prompting global shortages of the two products.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…